DLL3 and small cell lung carcinoma: Delta-like ligand 3 (DLL3), a Notch inhibitory ligand, is markedly up-regulated on SCLC cell surfaces, enhancing cell growth, metastasis and proliferation, which contributes to resistance against platinum-based chemotherapy (115).